News

Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)

Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE) Approval...

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared...

Tinley’s Provides Corporate Updates and Announces Appointment of New Director and the Closing of its Oversubscribed Non-Brokered Private Placement and Debt Settlement

Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - January 26, 2024) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB:...

error: Content is protected !!